Is buying TLX on Gotrade safe and legal?

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

What are the market hours to buy TLX?

You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours. Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.

How do I tell if TLX is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Telix Pharmaceuticals Limited American Depositary Shares (TLX) Stock Price Today & Analysis

Q: How do I buy Telix Pharmaceuticals Limited American Depositary Shares (TLX) stock?

Buying Telix Pharmaceuticals Limited American Depositary Shares (TLX) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and complete KYC. Make a deposit. Search for the code "TLX", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy TLX by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

Q: What is the minimum investment for TLX on Gotrade?

On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in Telix Pharmaceuticals Limited American Depositary Shares from just $1. A small budget shouldn't stop you from building a US stock portfolio.

Q: Does Telix Pharmaceuticals Limited American Depositary Shares (TLX) pay dividends?

At the moment, Telix Pharmaceuticals Limited American Depositary Shares (TLX) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track TLX's performance via the price chart in the Gotrade app.

% positive news of 5 articles

published over the past 14 days

Latest news

Investors Business Daily

Telix Beefs Up Radioisotopes Supply With $2.35 Billion Deal; Shares Crash

NeutralTLXSeptember 21, 2026

Investors Business DailyNeutral

Telix Beefs Up Radioisotopes Supply With $2.35 Billion Deal; Shares Crash

TLX

Reuters

Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion

NeutralTLXSeptember 20, 2026

ReutersNeutral

Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion

TLX

Stocktwits

TLX Stock Clocks 5% Gain This Week Ahead Of FDA Decision On Brain Cancer Imaging Agent

NeutralTLXSeptember 4, 2026

StocktwitsNeutral

TLX Stock Clocks 5% Gain This Week Ahead Of FDA Decision On Brain Cancer Imaging Agent

TLX

MarketBeat

Telix Pharmaceuticals H1 Earnings Call Highlights

NeutralTLXAugust 20, 2026

MarketBeatNeutral

Telix Pharmaceuticals H1 Earnings Call Highlights

TLX

Stocktwits

TLX Stock Surges Overnight After FDA Agrees To Review Brain Cancer Imaging Agent Application

NeutralTLXApril 10, 2026

StocktwitsNeutral

TLX Stock Surges Overnight After FDA Agrees To Review Brain Cancer Imaging Agent Application

TLX

About Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

SectorHealthcare

IndustryBiotechnology

Employees1,120

CEOMr. Raphael Ortiz L.L.B., M.B.A.

IPO DateNov 13, 2024

HeadquartersNorth Melbourne, VIC

Key Executives

Name	Title	Year Born
Mr. Darren Smith B.Bus., FCPA, M.B.A.	Group Chief Financial Officer	1965
Dr. Paul Schaffer	SVP of Research & Development	—
Mr. Craig Ulrick	Chief Information Officer	—
Ms. Kyahn Williamson B.A.	Senior Vice President of Corporate Communications & Investor Relations	—
Mr. Christian Krautkramer J.D.	Group General Counsel	—
Thomas Fromm	Vice President of Sales	—
Ms. Meredith Crowe BDES	Senior Vice President of Global People & Culture	—
Dr. Andreas Kluge M.D., Ph.D.	Chief Medical Advisor	1965
Ms. Odile Jaume M.B.A., M.Sc.	Advisor	—
Mr. Raphael Ortiz L.L.B., M.B.A.	Chief Executive Officer of Telix International	—

Fundamentals

Valuation

Market cap$3.89B

Price-to-sales ratio7.12

Price-to-book value11.40

Price-earnings ratio-764.50

Return on EquityN/A

Return on SalesN/A

Return on AssetsN/A

PEG ratioN/A

Earnings Per Share

Earnings Per ShareN/A

Income Statement

Average volume389,792

EBITDAN/A

1 year high (52w)$13.11

1 year low (52w)$6.28

Dividend

Ex dividend dateN/A

Dividend amount$0.00

Dividend yield0.00%

Last payment dateN/A

Dividend yield (TTM)N/A

Next earnings reportN/A

Solvency

Debt-to-equity ratioN/A

Technicals

OscillatorsStrong Sell5 Indicators

Moving AveragesNeutral12 Indicators

What the experts say

3 Wall Street Analyst Ratings

BUY

100% Buy

0% Hold

0% Sell

Target price

$21.33

Est return

85.83%

Citigroup

Laura Sutcliffe

Buy

Target price

$22.00

Est return

90.39%

Wedbush

David Nierengarten

Buy

Target price

$22.00

Est return

90.39%

HC Wainwright & Co.

Robert Burns

Buy

Target price

$20.00

Est return

73.09%

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2026									-7.2

Telix Pharmaceuticals Limited American Depositary Shares (TLX) Stock

Fundamentals

Recent news

Telix Beefs Up Radioisotopes Supply With $2.35 Billion Deal; Shares Crash

Telix Beefs Up Radioisotopes Supply With $2.35 Billion Deal; Shares Crash

Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion

Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion

TLX Stock Clocks 5% Gain This Week Ahead Of FDA Decision On Brain Cancer Imaging Agent

TLX Stock Clocks 5% Gain This Week Ahead Of FDA Decision On Brain Cancer Imaging Agent

Telix Pharmaceuticals H1 Earnings Call Highlights

Telix Pharmaceuticals H1 Earnings Call Highlights

Technicals

Analyst Ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Telix Beefs Up Radioisotopes Supply With $2.35 Billion Deal; Shares Crash

Telix Beefs Up Radioisotopes Supply With $2.35 Billion Deal; Shares Crash

Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion

Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion

TLX Stock Clocks 5% Gain This Week Ahead Of FDA Decision On Brain Cancer Imaging Agent

TLX Stock Clocks 5% Gain This Week Ahead Of FDA Decision On Brain Cancer Imaging Agent

Telix Pharmaceuticals H1 Earnings Call Highlights

Telix Pharmaceuticals H1 Earnings Call Highlights

TLX Stock Surges Overnight After FDA Agrees To Review Brain Cancer Imaging Agent Application

TLX Stock Surges Overnight After FDA Agrees To Review Brain Cancer Imaging Agent Application

About Telix Pharmaceuticals Limited American Depositary Shares

Key Executives

Fundamentals

Valuation

Earnings Per Share

Income Statement

Dividend

Solvency

Technicals

What the experts say

Seasonality

FAQ

Trading Lebih Cepat. Lebih Mudah. Lebih Cerdas.

#ReadyGoTrade